Cargando…
Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate
Mechanistic insights into the reaction of an estrogen o-quinone with deoxyguanosine has been further investigated using high level density functional calculations in addition to the use of 4-hyroxycatecholestrone (4-OHE(1)) regioselectivity labeled with deuterium at the C1-position. Calculations usi...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588807/ https://www.ncbi.nlm.nih.gov/pubmed/26378590 http://dx.doi.org/10.3390/metabo5030475 |
_version_ | 1782392690071044096 |
---|---|
author | Stack, Douglas E. |
author_facet | Stack, Douglas E. |
author_sort | Stack, Douglas E. |
collection | PubMed |
description | Mechanistic insights into the reaction of an estrogen o-quinone with deoxyguanosine has been further investigated using high level density functional calculations in addition to the use of 4-hyroxycatecholestrone (4-OHE(1)) regioselectivity labeled with deuterium at the C1-position. Calculations using the M06-2X functional with large basis sets indicate the tautomeric form of an estrogen-DNA adduct present when glycosidic bonds cleavage occurs is comprised of an aromatic A ring structure. This tautomeric form was further verified by use of deuterium labelling of the catechol precursor use to form the estrogen o-quinone. Regioselective deuterium labelling at the C1-position of the estrogen A ring allows discrimination between two tautomeric forms of a reaction intermediate either of which could be present during glycosidic bond cleavage. HPLC-MS analysis indicates a reactive intermediate with a m/z of 552.22 consistent with a tautomeric form containing no deuterium. This intermediate is consistent with a reaction mechanism that involves: (1) proton assisted Michael addition; (2) re-aromatization of the estrogen A ring; and (3) glycosidic bond cleavage to form the known estrogen-DNA adduct, 4-OHE(1)-1-N7Gua. |
format | Online Article Text |
id | pubmed-4588807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-45888072015-10-08 Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate Stack, Douglas E. Metabolites Article Mechanistic insights into the reaction of an estrogen o-quinone with deoxyguanosine has been further investigated using high level density functional calculations in addition to the use of 4-hyroxycatecholestrone (4-OHE(1)) regioselectivity labeled with deuterium at the C1-position. Calculations using the M06-2X functional with large basis sets indicate the tautomeric form of an estrogen-DNA adduct present when glycosidic bonds cleavage occurs is comprised of an aromatic A ring structure. This tautomeric form was further verified by use of deuterium labelling of the catechol precursor use to form the estrogen o-quinone. Regioselective deuterium labelling at the C1-position of the estrogen A ring allows discrimination between two tautomeric forms of a reaction intermediate either of which could be present during glycosidic bond cleavage. HPLC-MS analysis indicates a reactive intermediate with a m/z of 552.22 consistent with a tautomeric form containing no deuterium. This intermediate is consistent with a reaction mechanism that involves: (1) proton assisted Michael addition; (2) re-aromatization of the estrogen A ring; and (3) glycosidic bond cleavage to form the known estrogen-DNA adduct, 4-OHE(1)-1-N7Gua. MDPI 2015-09-10 /pmc/articles/PMC4588807/ /pubmed/26378590 http://dx.doi.org/10.3390/metabo5030475 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Stack, Douglas E. Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate |
title | Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate |
title_full | Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate |
title_fullStr | Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate |
title_full_unstemmed | Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate |
title_short | Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate |
title_sort | identifying the tautomeric form of a deoxyguanosine-estrogen quinone intermediate |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588807/ https://www.ncbi.nlm.nih.gov/pubmed/26378590 http://dx.doi.org/10.3390/metabo5030475 |
work_keys_str_mv | AT stackdouglase identifyingthetautomericformofadeoxyguanosineestrogenquinoneintermediate |